Showing results (1-10 of 253) with videos related to
Sort By:
Pageof 26
Cancer Journal (Sudbury, Mass.)|August 10, 2010
Artificial antigen-presenting cells for use in adoptive immunotherapyCameron J Turtle, Stanley R RiddellCurrent Opinion in Immunology|January 18, 2011
Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapyCameron J Turtle, Stanley R RiddellExpert Review of Hematology|September 21, 2012
Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantationMarie Bleakley, Cameron J Turtle, Stanley R RiddellCurrent Opinion in Immunology|July 24, 2012
Engineered T cells for anti-cancer therapyCameron J Turtle, Michael Hudecek, Michael C Jensen, et al.Current Opinion in Immunology|March 24, 2009
Adoptive transfer of virus-specific and tumor-specific T cell immunityCarolina Berger, Cameron J Turtle, Michael C Jensen, et al.Immunity|November 3, 2009
A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapyCameron J Turtle, Hillary M Swanson, Nobuharu Fujii, et al.Blood|October 28, 2011
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cellsSeitaro Terakura, Tori N Yamamoto, Rebecca A Gardner, et al.Blood|October 14, 2009
Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unitJonathan A Gutman, Cameron J Turtle, Thomas J Manley, et al.The Journal of Experimental Medicine|March 18, 2009
Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupusZhenpeng Dai, Cameron J Turtle, Garrett C Booth, et al.Cancer Journal (Sudbury, Mass.)|March 27, 2014
Adoptive therapy with chimeric antigen receptor-modified T cells of defined subset compositionStanley R Riddell, Daniel Sommermeyer, Carolina Berger, et al.Pageof 26